Search PubMed⌕ Search

Biomedical subjects

C L McIntosh

Publications and source records attributed to C L McIntosh.

At least 109 records · Page 6Linked to original sources

Drip retrograde coronary sinus perfusion for myocardial protection during aortic cross-clamping.

Moderate hypothermia is one of the methods utilized for myocardial protection when the aortic root is cross-clamped but not opened. A combination of low-pressure, low-flow retrograde coronary sinus perfusion (RCSP) with oxygenated blood at moderate hypothermia (29 degrees C.) was demonstrated to yield significantly better protection to left ventricular function in dogs than does moderate hypothermia alone. Ventricular function was recorded before and after 1 hour of aortic cross-clamping at identical preloads and heart rates. Aortic pressure was returned to a level as close to base line as possible by constriction of the descending aorta. The average mean aortic pressure of the animals perfused retrograde at 29 degrees C. was returned to within 4 per cent of base line. By contrast, in the animals protected with moderate hypothermia alone, the pressure could be returned only to a level which was 37 per cent lower than base line. In animals protected with moderate hypothermia alone, cardiac output dropped 62 per cent, left ventricular stroke work (LVSW) 75 per cent, and peak dp/dt 44 per cent. In the animals protected with RCSP and moderate hypothermia, the cardiac output dropped 6 per cent, LVSW 9 per cent, and peak dp/dt 5 per cent. The differences in the changes noted between these two groups were significant for LVSW and dp/dt at a level of p less than 0.01 and for cardiac output and aortic pressure at a level of p less than 0.05. These results suggest that RCSP may be indicated when moderate hypothermia is otherwise chosen to be the sole source of myocardial protection.

Animals↗

Atrioventricular valve replacement with the Hancock porcine xenograft: a five year clinical experience.

Since July, 1970, 111 patients have undergone mitral and/or tricuspid valve replacement with a glutaraldehyde-fixed porcine xenograft mounted on a flexible stent; 41 of these patients also had aortic valve replacement with a Starr-Edwards or Bjork-Shiley valve, and 85 patients presently are alive. Cumulative follow-up totals 2,060 months, with 16 patients followed more than 4 years. Anticoagulants have not been administered postoperatively, and one patient has had a systemic embolus. Postoperative hemodynamic assessments have been carried out in 54 patients, and in either the mitral or tricuspid position the valve was shown to have good hydraulic function. Significant mitral regurgitation, secondary to prosthetic dysfunction, occurred in one patient 56 months following implantation. Progressive prosthetic stenosis has not occurred, and hemolysis or anemia of clinical significance has not been observed as a consequence of the use of the use of the xenograft. To date, these clinical and hemodynamic data indicate that the glutaraldehyde-fixed xenograft, mounted on a flexible stent, is the prosthesis of choice for mitral and tricuspid valve replacement.

Aortic Valve↗